Loading...
Header Logo
Keywords
Last Name
Institution

JANIO SZKLARUK

TitleProfessor
InstitutionMD Anderson
DepartmentDiagnostic Radiology
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Saleh M, Virarkar M, Bura V, Valenzuela R, Javadi S, Szklaruk J, Bhosale P. Intrahepatic cholangiocarcinoma: pathogenesis, current staging, and radiological findings. Abdom Radiol (NY). 2020 May 16. PMID: 32417933.
      View in: PubMed
    2. Bathala TK, Venkatesan AM, Ma J, Bhosale P, Wei W, Kudchadker RJ, Wang J, Anscher MS, Tang C, Bruno TL, Frank SJ, Szklaruk J. Quality comparison between three-dimensional T2-weighted SPACE and two-dimensional T2-weighted turbo spin echo magnetic resonance images for the brachytherapy planning evaluation of prostate and periprostatic anatomy. Brachytherapy. 2020 May 10. PMID: 32402544.
      View in: PubMed
    3. Moawad AW, Szklaruk J, Lall C, Blair KJ, Kaseb AO, Kamath A, Rohren SA, Elsayes KM. Angiogenesis in Hepatocellular Carcinoma; Pathophysiology, Targeted Therapy, and Role of Imaging. J Hepatocell Carcinoma. 2020; 7:77-89. PMID: 32426302.
      View in: PubMed
    4. Szklaruk J, Son JB, Wei W, Bhosale P, Javadi S, Ma J. Comparison of free breathing and respiratory triggered diffusion-weighted imaging sequences for liver imaging. World J Radiol. 2019 Nov 28; 11(11):134-143. PMID: 31798795.
      View in: PubMed
    5. Fuentes D, Ahmed K, Lin JS, Abdel-Wahab R, Kaseb AO, Hassan M, Szklaruk J, Morshid A, Hazle JD, Qayyum A, Elsayes KM. Automated Volumetric Assessment of Hepatocellular Carcinoma Response to Sorafenib: A Pilot Study. J Comput Assist Tomogr. 2019 May 06. PMID: 31082984.
      View in: PubMed
    6. Fuentes D, Ahmed K, Lin JS, Abdel-Wahab R, Kaseb AO, Hassan M, Szklaruk J, Morshid A, Hazle JD, Qayyum A, Elsayes KM. Automated Volumetric Assessment of Hepatocellular Carcinoma Response to Sorafenib: A Pilot Study. J Comput Assist Tomogr. 2019 May/Jun; 43(3):499-506. PMID: 31082956.
      View in: PubMed
    7. Ganeshan D, Szklaruk J, Kaseb A, Kattan A, Elsayes KM. Fibrolamellar hepatocellular carcinoma: multiphasic CT features of the primary tumor on pre-therapy CT and pattern of distant metastases. Abdom Radiol (NY). 2018 12; 43(12):3340-3348. PMID: 29948061.
      View in: PubMed
    8. Yacoub JH, Elsayes KM, Fowler KJ, Hecht EM, Mitchell DG, Santillan C, Szklaruk J. Pitfalls in liver MRI: Technical approach to avoiding misdiagnosis and improving image quality. J Magn Reson Imaging. 2019 01; 49(1):41-58. PMID: 30295343.
      View in: PubMed
    9. Elsayes KM, Kielar AZ, Elmohr MM, Chernyak V, Masch WR, Furlan A, Marks RM, Cruite I, Fowler KJ, Tang A, Bashir MR, Hecht EM, Kamaya A, Jambhekar K, Kamath A, Arora S, Bijan B, Ash R, Kassam Z, Chaudhry H, McGahan JP, Yacoub JH, McInnes M, Fung AW, Shanbhogue K, Lee J, Deshmukh S, Horvat N, Mitchell DG, Do RKG, Surabhi VR, Szklaruk J, Sirlin CB. White paper of the Society of Abdominal Radiology hepatocellular carcinoma diagnosis disease-focused panel on LI-RADS v2018 for CT and MRI. Abdom Radiol (NY). 2018 10; 43(10):2625-2642. PMID: 30155697.
      View in: PubMed
    10. Elsayes KM, Menias CO, Morshid AI, Shaaban AM, Fowler KJ, Tang A, Chernyak V, Szklaruk J, Bashir MR. Spectrum of Pitfalls, Pseudolesions, and Misdiagnoses in Noncirrhotic Liver. AJR Am J Roentgenol. 2018 Jul; 211(1):97-108. PMID: 29932762.
      View in: PubMed
    11. Vu LN, Morelli JN, Szklaruk J. Basic MRI for the liver oncologists and surgeons. J Hepatocell Carcinoma. 2017; 5:37-50. PMID: 29692983.
      View in: PubMed
    12. Szklaruk J, Kaya D, Wei W. Evaluation of the added value of imaging the pelvis in patients with hepatocellular cancer. J Gastroenterol Hepatol. 2018 Feb; 33(2):500-502. PMID: 28612991.
      View in: PubMed
    13. Yam C, Murthy RK, Valero V, Szklaruk J, Shroff GS, Stalzer CJ, Buzdar AU, Murray JL, Yang W, Hortobagyi GN, Moulder SL, Arun B. A phase II study of tipifarnib and gemcitabine in metastatic breast cancer. Invest New Drugs. 2018 04; 36(2):299-306. PMID: 29374384.
      View in: PubMed
    14. Szklaruk J, Luersen G, Ma J, Wei W, Underwood M. Gd-EOB-DTPA based magnetic resonance imaging for predicting liver response to portal vein embolization. World J Radiol. 2017 Apr 28; 9(4):199-205. PMID: 28529683.
      View in: PubMed
    15. Zurstrassen CE, Bitencourt AGV, Guimaraes MD, Cavalcante ACBS, Tyng CJ, Amoedo MK, Matsushita Junior JPK, Szklaruk J, Marchiori E, Chojniak R. Percutaneous stent placement for the treatment of malignant biliary obstruction: nitinol versus elgiloy stents. Radiol Bras. 2017 Mar-Apr; 50(2):97-102. PMID: 28428652.
      View in: PubMed
    16. Elsayes KM, Kielar AZ, Agrons MM, Szklaruk J, Tang A, Bashir MR, Mitchell DG, Do RK, Fowler KJ, Chernyak V, Sirlin CB. Liver Imaging Reporting and Data System: an expert consensus statement. J Hepatocell Carcinoma. 2017; 4:29-39. PMID: 28255543.
      View in: PubMed
    17. Jensen CT, Telesmanich ME, Wagner-Bartak NA, Liu X, Rong J, Szklaruk J, Qayyum A, Wei W, Chandler AG, Tamm EP. Evaluation of Abdominal Computed Tomography Image Quality Using a New Version of Vendor-Specific Model-Based Iterative Reconstruction. J Comput Assist Tomogr. 2017 Jan; 41(1):67-74. PMID: 27529683.
      View in: PubMed
    18. Luersen GF, Wei W, Tamm EP, Bhosale PR, Szklaruk J. Evaluation of Magnetic Resonance (MR) Biomarkers for Assessment of Response With Response Evaluation Criteria in Solid Tumors: Comparison of the Measurements of Neuroendocrine Tumor Liver Metastases (NETLM) With Various MR Sequences and at Multiple Phases of Contrast Administration. J Comput Assist Tomogr. 2016 Sep-Oct; 40(5):717-22. PMID: 27636124.
      View in: PubMed
    19. Yedururi S, Kang HC, Wei W, Wagner-Bartak NA, Marcal LP, Stafford RJ, Willis BJ, Szklaruk J. Free-breathing radial volumetric interpolated breath-hold examination vs breath-hold cartesian volumetric interpolated breath-hold examination magnetic resonance imaging of the liver at 1.5T. World J Radiol. 2016 Jul 28; 8(7):707-15. PMID: 27551341.
      View in: PubMed
    20. Lim TY, Kudchadker RJ, Wang J, Bathala T, Szklaruk J, Pugh TJ, Mahmood U, Ibbott GS, Frank SJ. Development of a magnetic resonance imaging protocol to visualize encapsulated contrast agent markers in prostate brachytherapy recipients: initial patient experience. J Contemp Brachytherapy. 2016 Jun; 8(3):235-42. PMID: 27504133.
      View in: PubMed
    21. Luersen GF, Bhosale P, Szklaruk J. State-of-the-art cross-sectional liver imaging: beyond lesion detection and characterization. J Hepatocell Carcinoma. 2015; 2:101-17. PMID: 27508199.
      View in: PubMed
    22. Morani AC, Vicens RA, Wei W, Gupta S, Vikram R, Balachandran A, Reed BJ, Ma J, Qayyum A, Szklaruk J. CAIPIRINHA-VIBE and GRAPPA-VIBE for liver MRI at 1.5 T: a comparative in vivo patient study. J Comput Assist Tomogr. 2015 Mar-Apr; 39(2):263-9. PMID: 25635931.
      View in: PubMed
    23. Faria SC, Szklaruk J, Kaseb AO, Hassabo HM, Elsayes KM. TNM/Okuda/Barcelona/UNOS/CLIP International Multidisciplinary Classification of Hepatocellular Carcinoma: concepts, perspectives, and radiologic implications. Abdom Imaging. 2014 Oct; 39(5):1070-87. PMID: 24695938.
      View in: PubMed
    24. Testa ML, Chojniak R, Sene LS, Damascena AS, GuimarĂ£es MD, Szklaruk J, Marchiori E. Is DWI/ADC a useful tool in the characterization of focal hepatic lesions suspected of malignancy? PLoS One. 2014; 9(7):e101944. PMID: 25025151.
      View in: PubMed
    25. Ganeshan D, Szklaruk J, Kundra V, Kaseb A, Rashid A, Elsayes KM, Elsayes K. Imaging features of fibrolamellar hepatocellular carcinoma. AJR Am J Roentgenol. 2014 Mar; 202(3):544-52. PMID: 24555590.
      View in: PubMed
    26. Neperud J, Mahvash A, Garg N, Murthy R, Szklaruk J. Can imaging patterns of neuroendocrine hepatic metastases predict response yttruim-90 radioembolotherapy? World J Radiol. 2013 Jun 28; 5(6):241-7. PMID: 23807902.
      View in: PubMed
    27. Morani AC, Elsayes KM, Liu PS, Weadock WJ, Szklaruk J, Dillman JR, Khan A, Chenevert TL, Hussain HK. Abdominal applications of diffusion-weighted magnetic resonance imaging: Where do we stand. World J Radiol. 2013 Mar 28; 5(3):68-80. PMID: 23671743.
      View in: PubMed
    28. Ganeshan DM, Szklaruk J. Portal vein embolization: cross-sectional imaging of normal features and complications. AJR Am J Roentgenol. 2012 Dec; 199(6):1275-82. PMID: 23169719.
      View in: PubMed
    29. Ganeshan D, Moron FE, Szklaruk J. Extrahepatic biliary cancer: New staging classification. World J Radiol. 2012 Aug 28; 4(8):345-52. PMID: 22937214.
      View in: PubMed
    30. Tamm EP, Szklaruk J, Puthooran L, Stone D, Stevens BL, Modaro C. Quality initiatives: planning, setting up, and carrying out radiology process improvement projects. Radiographics. 2012 Sep-Oct; 32(5):1529-42. PMID: 22745219.
      View in: PubMed
    31. Patnana M, Bronstein Y, Szklaruk J, Bedi DG, Hwu WJ, Gershenwald JE, Prieto VG, Ng CS. Multimethod imaging, staging, and spectrum of manifestations of metastatic melanoma. Clin Radiol. 2011 Mar; 66(3):224-36. PMID: 21295201.
      View in: PubMed
    32. Asran M, Rashid A, Szklaruk J. Hepatic endometriosis mimicking metastatic disease: a case report and review of the literature. J Radiol Case Rep. 2010; 4(11):26-31. PMID: 22470699.
      View in: PubMed
    33. Maniam S, Szklaruk J. Magnetic resonance imaging: Review of imaging techniques and overview of liver imaging. World J Radiol. 2010 Aug 28; 2(8):309-22. PMID: 21160685.
      View in: PubMed
    34. Merkle EM, Szklaruk J, Taouli B. Imaging techniques in the diagnosis of hepatocellular carcinoma and metastatic carcinoma as a result of colon cancer. Gastroenterol Hepatol (N Y). 2010 Aug; 6(8):1-16. PMID: 21475387.
      View in: PubMed
    35. Ozkan E, Balachandran A, Bhosale PR, Tamm EP, Marcal LP, Szklaruk J. Pictorial essay: multimodality imaging of metastases from pancreatic ductal adenocarcinoma. Clin Imaging. 2010 Jul-Aug; 34(4):277-87. PMID: 20630340.
      View in: PubMed
    36. Le-Petross H, Kundra V, Szklaruk J, Wei W, Hortobagyi GN, Ma J. Fast three-dimensional dual echo dixon technique improves fat suppression in breast MRI. J Magn Reson Imaging. 2010 Apr; 31(4):889-94. PMID: 20373433.
      View in: PubMed
    37. Bhosale P, Szklaruk J, Iyer R. Multimodality imaging of usual and unusual sites of metastasis which occur after definitive therapy for rectal cancer. Clin Imaging. 2010 Mar-Apr; 34(2):100-8. PMID: 20189072.
      View in: PubMed
    38. Kobayashi K, Szklaruk J, Trent JC, Ensor J, Ahrar K, Wallace MJ, Madoff DC, Murthy R, Hicks ME, Gupta S. Hepatic arterial embolization and chemoembolization for imatinib-resistant gastrointestinal stromal tumors. Am J Clin Oncol. 2009 Dec; 32(6):574-81. PMID: 19636238.
      View in: PubMed
    39. Tamm EP, Balachandran A, Bhosale P, Szklaruk J. Update on 3D and multiplanar MDCT in the assessment of biliary and pancreatic pathology. Abdom Imaging. 2009 Jan-Feb; 34(1):64-74. PMID: 18483805.
      View in: PubMed
    40. Borghero Y, Crane CH, Szklaruk J, Oyarzo M, Curley S, Pisters PW, Evans D, Abdalla EK, Thomas MB, Das P, Wistuba II, Krishnan S, Vauthey JN. Extrahepatic bile duct adenocarcinoma: patients at high-risk for local recurrence treated with surgery and adjuvant chemoradiation have an equivalent overall survival to patients with standard-risk treated with surgery alone. Ann Surg Oncol. 2008 Nov; 15(11):3147-56. PMID: 18754070.
      View in: PubMed
    41. Bhosale PR, Patnana M, Viswanathan C, Szklaruk J. The inguinal canal: anatomy and imaging features of common and uncommon masses. Radiographics. 2008 May-Jun; 28(3):819-35; quiz 913. PMID: 18480486.
      View in: PubMed
    42. Beddar AS, Briere TM, Balter P, Pan T, Tolani N, Ng C, Szklaruk J, Krishnan S. 4D-CT imaging with synchronized intravenous contrast injection to improve delineation of liver tumors for treatment planning. Radiother Oncol. 2008 Jun; 87(3):445-8. PMID: 18194819.
      View in: PubMed
    43. MorĂ³n FE, Szklaruk J. Learning the nodal stations in the abdomen. Br J Radiol. 2007 Oct; 80(958):841-8. PMID: 17959923.
      View in: PubMed
    44. Szklaruk J, Bhosale P. Hepatocellular carcinoma: MRI and CT examination. Isr Med Assoc J. 2007 Mar; 9(3):153-5. PMID: 17402324.
      View in: PubMed
    45. Yao JC, Zhang JX, Rashid A, Yeung SC, Szklaruk J, Hess K, Xie K, Ellis L, Abbruzzese JL, Ajani JA. Clinical and in vitro studies of imatinib in advanced carcinoid tumors. Clin Cancer Res. 2007 Jan 01; 13(1):234-40. PMID: 17200360.
      View in: PubMed
    46. Bhosale P, Szklaruk J, Silverman PM. Current staging of hepatocellular carcinoma: imaging implications. Cancer Imaging. 2006 Jul 04; 6:83-94. PMID: 16829469.
      View in: PubMed
    47. Mehta S, Szklaruk J, Faria SC, Raymond AK, Whitman GJ. Radiologic-pathologic conferences of the University of Texas M. D. Anderson Cancer Center: Chondromyxoid fibroma of the sacrum and left iliac bone. AJR Am J Roentgenol. 2006 Feb; 186(2):467-9. PMID: 16423954.
      View in: PubMed
    48. Silverman PM, Szklaruk J. Controversies in imaging of hepatocellular carcinoma: multidetector CT (MDCT). Cancer Imaging. 2005 Dec 10; 5:178-87. PMID: 16361147.
      View in: PubMed
    49. Murthy R, Nunez R, Szklaruk J, Erwin W, Madoff DC, Gupta S, Ahrar K, Wallace MJ, Cohen A, Coldwell DM, Kennedy AS, Hicks ME. Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications. Radiographics. 2005 Oct; 25 Suppl 1:S41-55. PMID: 16227496.
      View in: PubMed
    50. Oto A, Tamm EP, Szklaruk J. Multidetector row CT of the liver. Radiol Clin North Am. 2005 Sep; 43(5):827-48, vii. PMID: 16098342.
      View in: PubMed
    51. Murthy R, Xiong H, Nunez R, Cohen AC, Barron B, Szklaruk J, Madoff DC, Gupta S, Wallace MJ, Ahrar K, Hicks ME. Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: preliminary results. J Vasc Interv Radiol. 2005 Jul; 16(7):937-45. PMID: 16002501.
      View in: PubMed
    52. Devine C, Szklaruk J, Tamm EP. Magnetic resonance imaging in the characterization of pelvic masses. Semin Ultrasound CT MR. 2005 Jun; 26(3):172-204. PMID: 15987066.
      View in: PubMed
    53. Faria SC, Tamm EP, Varavithya V, Phongkitkarun S, Kaur H, Szklaruk J, Dubrow R, Charnsangavej C. Systematic approach to the analysis of cross-sectional imaging for surveillance of recurrent colorectal cancer. Eur J Radiol. 2005 Mar; 53(3):387-96. PMID: 15741012.
      View in: PubMed
    54. Patel MR, Tse V. Diagnosis and staging of brain tumors. Semin Roentgenol. 2004 Jul; 39(3):347-60. PMID: 15372749.
      View in: PubMed
    55. Faria SC, Tamm EP, Loyer EM, Szklaruk J, Choi H, Charnsangavej C. Diagnosis and staging of pancreatic tumors. Semin Roentgenol. 2004 Jul; 39(3):397-411. PMID: 15372753.
      View in: PubMed
    56. Khatti S, Faria SC, Medeiros LJ, Szklaruk J. Myeloid sarcoma of the appendix mimicking acute appendicitis. AJR Am J Roentgenol. 2004 May; 182(5):1194. PMID: 15100117.
      View in: PubMed
    57. Szklaruk J, Tamm EP, Choi H, Varavithya V. MR imaging of common and uncommon large pelvic masses. Radiographics. 2003 Mar-Apr; 23(2):403-24. PMID: 12640156.
      View in: PubMed
    58. Szklaruk J, Silverman PM, Charnsangavej C. Imaging in the diagnosis, staging, treatment, and surveillance of hepatocellular carcinoma. AJR Am J Roentgenol. 2003 Feb; 180(2):441-54. PMID: 12540450.
      View in: PubMed
    59. Szklaruk J, Tamm E, Charnsangavej C. Preoperative imaging of biliary tract cancers. Surg Oncol Clin N Am. 2002 Oct; 11(4):865-76. PMID: 12607576.
      View in: PubMed
    60. Tamm E, Charnsangavej C, Szklaruk J. Advanced 3-D imaging for the evaluation of pancreatic cancer with multidetector CT. Int J Gastrointest Cancer. 2001; 30(1-2):65-71. PMID: 12489581.
      View in: PubMed
    61. Ito K, Mitchell DG, Outwater EK, Szklaruk J, Sadek AG. Hepatic lesions: discrimination of nonsolid, benign lesions from solid, malignant lesions with heavily T2-weighted fast spin-echo MR imaging. Radiology. 1997 Sep; 204(3):729-37. PMID: 9280251.
      View in: PubMed
    62. Evaluation of Magnetic Resonance (MR) Biomarkers for Assessment of Response with Response Evaluation Criteria in Solid Tumors. Journal of Computer Assisted Tomography. 40:717-722.
    63. Extramedullary hematopoiesis mimicking hepatocellular carcinoma. Applied Radiology. 39:59-60.
    64. Liver cancer. 95-119.
    65. MR contrast agents. Applied Radiology. 39:26-42.
    66. Gadolinium-enhanced imaging to identify metastatic lesions. Gastroenterology and Hepatology. 6:9-12.
    67. Evaluation of Abdominal Computed Tomography Image Quality Using a New Version of Vendor-Specific Model-Based Iterative Reconstruction. Journal of Computer Assisted Tomography.
    68. Development of a magnetic resonance imaging protocol to visualize encapsulated contrast agent markers in prostate brachytherapy recipients. Journal of Contemporary Brachytherapy. 8:233-240.
    69. Aqueous shift reagents for high-resolution cation NMR spectroscopy. 4. DybPPPpob5-. Inorganic Chemistry. 29:660-667.
    70. Cholangiocarcinoma. 121-151.
    71. Improving MRI imaging/protocol processes using lean and DMAIC methodology.
    72. MDCT. Applied Radiology. 42:24-34.
    73. Contrast usage for liver imaging in the era of MSCT, MDCT. Applied Radiology. 32:26-34.
    74. Radiological case of the month. Applied Radiology. 30:40-42.
    75. MR angiography of tumor-related vasculature. Radiographics. 25.
    SZKLARUK's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description